Meeting
2018 Gastrointestinal Cancers Symposium
Role of stereotactic body radiation therapy in patients with hepatocellular carcinoma extensively pretreated with transarterial chemoembolization or yttrium-90.
Authors
Kayo Tanimoto
University of Loyola Chicago Stritch School of Medicine, Maywood, IL
Kayo Tanimoto , Iris Rusu , Brendan Martin , Jennifer Price , Tarita Thomas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 233)
DOI
10.1200/JCO.2018.36.4_suppl.233
Abstract #
233
Poster Bd #
B8
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Stereotactic-body radiotherapy for portal vein tumor thrombosis in hepatocellular carcinoma patients.
First Author: Bae Kwon Jeong
Poster
2016 ASCO Annual Meeting
Stereotactic body radiotherapy (SBRT) as an alternative to transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC).
First Author: Eli Sapir
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Comparing resection and stereotactic body radiation therapy for hepatocellular carcinoma with macrovascular invasion: A propensity score matched study.
First Author: Michael Yan
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase I clinical trial of stereotactic body radiotherapy with atezolizumab and bevacizumab in advanced hepatocellular carcinoma.
First Author: Timothy J Brown